Seres Therapeutics, a leading microbiome therapeutics company, entered into a new $250 million senior secured debt facility ("Term Loan Facility") provided by funds managed by Oaktree Capital Management. The Company drew the first tranche of $110...
Read Story
|
Locus Fermentation Solutions (Locus FS), a green tech company that produces biological alternatives to chemicals that advance decarbonization goals, has secured $117 million in IP-insurance backed debt financing arranged by Jefferies, bringing its...
Read Story
|
Gamida Cell closed a senior secured convertible term loan of $25 million with certain funds managed by Highbridge Capital Management, LLC. Pursuant to the loan agreement, Gamida Cell’s wholly-owned subsidiary, as borrower, will draw down $25 million...
Read Story
December 12, 2022, 08:10 AM
|
Monroe Capital acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of Biomechanical Research & Testing, LLC (“BRT”) by Aperture, LLC (“Aperture”), a portfolio company of Trinity...
Read Story
|
Eyenovia entered into a new $25 million credit financing facility with Silicon Valley Bank.“This non-dilutive credit facility provides us with a significant amount of financial and operating flexibility at terms that we believe are favorable to the...
Read Story
|
Rezolute entered into a $30 million debt financing agreement with investment affiliates managed by SLR Capital Partners.Fifteen million of the $30 million loan was funded upon closing with an interest only period of 24 months. The remaining fifteen...
Read Story
|
Monroe Capital acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of Serán Bioscience, Inc. by private equity sponsor Vivo Capital LLC.Founded in 2016 and located in Bend, Oregon...
Read Story
January 08, 2021, 08:30 AM
|
Kerecis Limited, a regenerative-medicine biologics company, has secured $21 million in new financing. Silicon Valley Bank is providing a revolving line of credit of up to $15 million to meet the company’s near-term working-capital needs. Also, the...
Read Story
August 27, 2020, 08:45 AM
|
Orchard Therapeutics, a commercial-stage biopharmaceutical company, announced financial results for the quarter ended March 31, 2019 and provided several program updates related to its neurometabolic disease portfolio. Orchard has brought forward the...
Read Story
|
ADMA Biologics, Inc., a vertically integrated commercial biopharmaceutical company that develops, manufactures and markets specialty plasma-based biologics for the prevention and treatment of certain infectious and immunological diseases, announced...
Read Story
October 11, 2017, 07:05 AM
|
Emergent BioSolutions Inc. announced that it has completed a new five-year, $200 million syndicated senior secured credit facility. This new facility replaces and represents an increase from the company's prior $100 million facility, which was...
Read Story
October 02, 2017, 08:00 AM
|
Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, announced the closing of a $10 million senior secured term loan with Oxford BioTherapeutics, an international, clinical-stage...
Read Story
January 27, 2017, 07:00 AM
|
Monroe Capital LLC announced it acted as sole lead arranger and administrative agent on the funding of a $20 million senior credit facility to support the growth of Cytovance Biologics, Inc. by private equity sponsor, Great Point Partners.Based in...
Read Story
October 28, 2014, 07:53 AM
|